Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance

BACKGROUND: The loss of chloroquine (CQ) effectiveness has led to its withdrawal from national policies as a first-line treatment for uncomplicated malaria in several endemic countries, such as the Democratic Republic of Congo (DRC). The K76T mutation on the pfcrt gene has been identified as a marke...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Malar J
Asıl Yazarlar: Yobi, Doudou M., Kayiba, Nadine K., Mvumbi, Dieudonné M., Boreux, Raphael, Kabututu, Pius Z., Situakibanza, Hippolyte N. T., Likwela, Joris L., De Mol, Patrick, Okitolonda, Emile W., Speybroeck, Niko, Mvumbi, Georges L., Hayette, Marie-Pierre
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7085146/
https://ncbi.nlm.nih.gov/pubmed/32197607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-020-03192-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller